SE8304332D0 - Arzneimittel mit cytostatischer wirkung - Google Patents

Arzneimittel mit cytostatischer wirkung

Info

Publication number
SE8304332D0
SE8304332D0 SE8304332A SE8304332A SE8304332D0 SE 8304332 D0 SE8304332 D0 SE 8304332D0 SE 8304332 A SE8304332 A SE 8304332A SE 8304332 A SE8304332 A SE 8304332A SE 8304332 D0 SE8304332 D0 SE 8304332D0
Authority
SE
Sweden
Prior art keywords
medicine
cytostatic effect
fatty acids
cytostatic
short
Prior art date
Application number
SE8304332A
Other languages
English (en)
Other versions
SE8304332L (sv
Inventor
Heinrich Schulze
Friedrich Karl Erichsen
Wolfgang Fischer
Original Assignee
Heinrich Schulze
Friedrich Karl Erichsen
Wolfgang Fischer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heinrich Schulze, Friedrich Karl Erichsen, Wolfgang Fischer filed Critical Heinrich Schulze
Publication of SE8304332D0 publication Critical patent/SE8304332D0/sv
Publication of SE8304332L publication Critical patent/SE8304332L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8304332A 1982-08-12 1983-08-09 Lekemedel med cytostatisk verkan SE8304332L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823229956 DE3229956A1 (de) 1982-08-12 1982-08-12 Arzneimittel mit cytostatischer wirkung

Publications (2)

Publication Number Publication Date
SE8304332D0 true SE8304332D0 (sv) 1983-08-09
SE8304332L SE8304332L (sv) 1984-02-13

Family

ID=6170656

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8304332A SE8304332L (sv) 1982-08-12 1983-08-09 Lekemedel med cytostatisk verkan

Country Status (6)

Country Link
BE (1) BE897535A (sv)
DE (1) DE3229956A1 (sv)
FR (1) FR2531632A1 (sv)
LU (1) LU84951A1 (sv)
NL (1) NL8302829A (sv)
SE (1) SE8304332L (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2633929B2 (fr) * 1987-09-25 1995-05-24 Picardie Universite Derives non toxiques de l'acide n-butyrique, presentant des actions therapeutiques retardees
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
JPH01299222A (ja) * 1988-05-26 1989-12-04 Otsuka Pharmaceut Factory Inc 抗腫瘍剤
FR2723096B1 (fr) * 1994-07-28 1996-10-18 Univ Picardie Esters associant les acides phenylacetique,3-phenyl-propionique, 4-phenyl-butyrique et n-butyrique au d-mannose, au xylitol et a leurs derives. applications comme medicaments
US8105809B2 (en) 2008-07-03 2012-01-31 Accera, Inc. Enzymatic synthesis of acetoacetate esters and derivatives
EP3609484A4 (en) * 2017-04-12 2020-12-16 Cavaleri, Franco BUTYRATE AND BETA HYDROXYBUTYRATE COMPOSITIONS AND METHODS FOR THEIR USE

Also Published As

Publication number Publication date
DE3229956A1 (de) 1984-02-16
LU84951A1 (de) 1983-12-28
BE897535A (fr) 1983-12-01
FR2531632A1 (fr) 1984-02-17
SE8304332L (sv) 1984-02-13
NL8302829A (nl) 1984-03-01
FR2531632B3 (sv) 1985-03-08

Similar Documents

Publication Publication Date Title
NL930095I2 (nl) Aromatische heterocyclische esters van steroiden, de bereiding daarvan en farmaceutische composities, die deze verbindingen bevatten.
DE69114498D1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
RU94000061A (ru) Эфиры холестерина и ненасыщенных жирных кислот, способ лечения и фармацевтическая или косметическая композиция
AR230268A1 (es) Procedimiento para la preparacion de acidos y esteres 4-amino-3-quinolincarboxilicos
MX5723A (es) Procedimiento para la preparacion de n-tiazolimetiltio-alquil-n`-alquilamidinas producto obtenido y composicion farmaceutica que lo incluye
AR193271A1 (es) Esteres de acidos ciclopropanocarboxilico,proceso para su preparacion y composiciones insecticidas que las contienen
IT8319306A0 (it) Composizione di antralina oppure di uno dei suoi derivati in un estere aromatico e suo impiego nel trattamento di malattie della pelle e delle unghie.
IT9047618A0 (it) Esteri di acil-l-carnitine con l'acido gamma-idrossibutirrico e composizioni farmaceutiche che li contengono per l'inibizione della degenerazione neuronale e nel trattamento del coma.
MX5999E (es) Procedimiento para la preparacion de composiciones farmaceuticas que contienen fumarato de benciclano y ciclodextrina
AT285812B (de) Verfahren zur Herstellung neuer Phosphorsäureester des Lincomycins und dessen Derivaten in 2-Stellung
ATE22532T1 (de) Pharmazeutische zusammensetzung.
NZ190842A (en) 4-substituted-thiazole-2-oxamic acids and esters and pharmaceutical compositions
SE8304332D0 (sv) Arzneimittel mit cytostatischer wirkung
IE772666L (en) Pharmaceutical composition
IT1106299B (it) 5-imminodaunomicina e suoi derivati procedimento per prepararla nonch' composizioni farmaceutiche che la contengono
SE8800988L (sv) Farmaceutiska kompositioner med verkan paa hjaertat och det kardiovaskulaera systemet samt foerfarande foer framstaellning av desamma
SE8800989L (sv) Dietkomposition samt foerfarande foer framstaellning av densamma
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
IL56442A0 (en) Pharmaceutical compositions comprising an adipic aced ester derivative and their use in the prophylaxis and/or treatment of certain desease
ES2063056T3 (es) Esteres poliaromaticos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
SE8304331D0 (sv) Arzneimittel mit analgetischer wirkung
ES2063765T3 (es) Esteres cicloalifaticos insaturados de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
AT277994B (de) Verfahren zur Herstellung von 1-Aroylindol-3-essigsäuren und deren Estern
ES2063057T3 (es) Esteres aromaticos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
IT1143905B (it) Procedimento per diminuire il contenuto di fenilalanina in idrozzati porteici e in prodotti preparati da questi

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8304332-3

Format of ref document f/p: F